Möchten Sie immer auf dem neuesten Stand bleiben?

BASEL, Switzerland, April 02, 2004 (PRIMEZONE) -- Roche will publish its Sales Results for the 1st Quarter of 2004 prior to the opening of the Swiss Stock Exchange on Wednesday, 21st April...

BASEL, Switzerland, Feb. 4, 2004 (PRIMEZONE) -- Roche Group in 2003 -- Roche posts double-digit sales gains in core businesses, up 19% in local currencies (11% in CHF) to 29.0 billion CHF...

BASEL, Switzerland, Jan. 26, 2004 (PRIMEZONE) -- Details of release, presentations and material Change in time for London event February 4, 2004 07.00 CET (Central European time) Release...

BASEL, Switzerland, Jan. 5, 2004 (PRIMEZONE) -- 4 February am - Conference call 4 February pm - Presentation in London 5 February pm - Presentation in New York February 4, 2004 Roche...

BASEL, Switzerland, Dec. 05, 2003 (PRIMEZONE) -- Roche today announced the submission of a Marketing Authorisation application to the European Union for Avastin (bevacizumab, rhuMAb-VEGF) as a...

BASEL, Switzerland, Oct. 16, 2003 (PRIMEZONE) -- Roche Group (Other OTC:RHHBY): -- Roche Group posts marked double-digit growth in core businesses; sales up 19% in local currencies and 10%...

BASEL, Switzerland, Sept. 16, 2003 (PRIMEZONE) -- Roche (Other OTC:RHHBY) will publish its sales results for the 3rd Quarter of 2003 at 07.00h (CET) on Thursday, 16th October...

BASEL, Switzerland, July 28, 2003 (PRIMEZONE) -- Roche announced today that the European CPMP has issued a positive opinion for the use of oral and intravenous Bondronat (ibandronate) "prevention of...

BASEL, Switzerland, , July 23, 2003 (PRIMEZONE) -- Roche: - Combined sales in the Group's core Pharmaceuticals and Diagnostics Divisions up 17% in local currencies (+6% in CHF). - Group...

BASEL, Switzerland, July 17, 2003 (PRIMEZONE) -- Roche: 23 July 2003, 7 CET -- release will be e-mailed and posted on the Roche IR website. Presentation slides and the Half Year Report 2003 will be...